Votrient Tablet, Film Coated
Product Images NDC 0078-1077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Votrient (NDC 0078-1077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Votrient 01

Votrient 01
This is a description for a medication called Votrient, which comes in tablet form. The package contains 120 tablets, each with a strength of 200 mg. The manufacturer of the medication is Novartis, and the product is identified as NDG 0078-0670-00. The medication contains pazopanib and is produced in Singapore.*
FDA Label Image

The Following Chemical Structure For Votrient (pazopanib) Is A Tyrosine Kinase Inhibitor (tki). Pazopanib Is Presented As The Hydrochloride Salt, With The Chemical Name 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide Monohydrochloride. It Has The Molecular Formula C21h23n7o2s•hcl And A Molecular Weight Of 473.99. (Votrient 02)

The Following Chemical Structure For Votrient (pazopanib) Is A Tyrosine Kinase Inhibitor (tki). Pazopanib Is Presented As The Hydrochloride Salt, With The Chemical Name 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide Monohydrochloride. It Has The Molecular Formula C21h23n7o2s•hcl And A Molecular Weight Of 473.99. (Votrient 02)
FDA Label Image

Figure 1. Kaplan-meier Curve For Progression-free Survival In Rcc By Independent Assessment For The Overall Population (treatment-naïve And Cytokine Pre-treated Populations) (Votrient 03)

Figure 1. Kaplan-meier Curve For Progression-free Survival In Rcc By Independent Assessment For The Overall Population (treatment-naïve And Cytokine Pre-treated Populations) (Votrient 03)
Not available.*
FDA Label Image

Figure 2. Kaplan-meier Curve For Progression-free Survival In Sts By Independent Assessment For The Overall Population (Votrient 04)

Figure 2. Kaplan-meier Curve For Progression-free Survival In Sts By Independent Assessment For The Overall Population (Votrient 04)
FDA Label Image

Principal Display Panelndc 0078-0670-66votrient(pazopanlb)tablets200 mg120 Tabletsrx Only (Votrient 05)

Principal Display Panelndc 0078-0670-66votrient(pazopanlb)tablets200 mg120 Tabletsrx Only (Votrient 05)
This is a description of the drug Votrient (pazopanib) manufactured by NovarTIs Llaas. The text includes instructions not to use it in pregnancy and mentions a tablet safety seal under the cap. The rest of the text is not-readable and contains non-English characters, so additional information cannot be provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.